Skip to content

Author

Xue-Feng Leng

We have 18 of 228 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Anastomotic leak after esophagectomy for cancer in enhanced recovery protocol versus conventional care: clinical characteristics and outcomes

Background Anastomotic leak (AL) is the most concerning complication after esophagectomy in the Enhanced Recovery After Surgery (ERAS) protocol. This retrospective cohort study aimed to compare the clinical characteristics and outcomes of postoperative AL in esophageal cancer patients under the ERAS protocol versus tho...

Yu-Hao Wen, Yi-Xuan Huang, Kang-Jun Wang et al. · 0 citations
Aug 2026

P1.154. Delayed Unexplained Hemorrhage After Esophagectomy: Insights From a Nationwide Multicenter Questionnaire-Based Study

Esophageal Cancer: Surgical Treatment of Esophageal Cancer – early outcomes and complications Delayed unexplained postoperative hemorrhage after esophagectomy is a rare complication. Due to its low incidence, existing reports are limited, and high-quality evidence regarding its clinical characteristics, ri...

Xue-Feng Leng, Jicheng Xiong, Yong Li · 0 citations
Open access Sep 2026

Comparative outcomes of neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in locally advanced thoracic esophageal squamous cell carcinoma: a target trial emulation

Background Neoadjuvant chemoradiotherapy (NCRT) is standard for locally advanced esophageal squamous cell carcinoma (ESCC), while neoadjuvant immune-chemotherapy (NICT) is a promising alternative. This study compared pathological response and long-term survival between NICT and NCRT followed by surgery using a target t...

Zhi-Yu Li, Qiu-Xi Zhou, Qin Xie et al. · 0 citations
Open access Aug 2026

PD05.07. Enhancing SAM-Med3D with Prototype-Contrast Boundary Optimization for Esophageal Squamous Cell Carcinoma Segmentation

Esophageal Cancer: Other Precise segmentation of esophageal squamous cell carcinoma (ESCC) lesions on CT imaging is essential for treatment planning. While the Segment Anything Model for 3D medical images (SAM-Med3D) shows promise, its performance in delineating tumor boundaries remains suboptimal. We prop...

Si-miao Lu, Yi Zhu, Yong-Tao Han et al. · 0 citations
Open access Aug 2026

PD09.07. Impact of Type 2 Diabetes on Outcomes of Neoadjuvant Therapy and Surgery for Esophageal Cancer: A Multi-Center Retrospective Study

Esophageal Cancer: Surgical Treatment of Esophageal Cancer – early outcomes and complications The prognostic impact of type 2 diabetes in esophageal cancer patients receiving neoadjuvant therapy followed by surgery remains unclear. We evaluated its association with perioperative outcomes and long-term surv...

Xi-Peng Wang, Zhi-Chao Liu, Xue-Feng Leng et al. · 0 citations
Aug 2026

P1.155. Impact of Lymphaticvessel Invasion on Prognosis in Patients With Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Immunochemotherapy: A Multicenter Retrospective Study

Esophageal Cancer: Surgical Treatment of Esophageal Cancer Prognostic stratification remains inadequate in patients with locally advanced esophageal squamous cell carcinoma (ESCC) following neoadjuvant immunotherapy combined with chemotherapy (NICT). This multicenter study aimed to determine the prognostic...

Xue-Feng Leng, Jicheng Xiong, zigang li · 0 citations
Open access Aug 2026

P1.066. Prognostic Equivalence of ypN and pN Staging in Esophageal Cancer After Neoadjuvant Therapy: A Multicenter Cohort Study of 2,545 Patients

Findings challenge the unconditional interchangeability of ypN and pN in current staging systems and have direct implications for adjuvant treatment decision-making after neoadjuvant esophageal cancer therapy.

Si-miao Lu, Xue-Feng Leng · 0 citations
Open access Aug 2026

P1.071. Perioperative Patient-Reported Outcomes After Robot-Assisted Versus Conventional Minimally Invasive Esophagectomy for Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis

Findings support RAMIE as a viable alternative with comparable patient-centered outcomes, though the higher anastomotic leak rate warrants further investigation.

Si-miao Lu, Yi Zhu, Yong-Tao Han et al. · 0 citations
Aug 2026

P1.067. Multinational Comparison of Surgical Approaches and Postoperative Outcomes in Esophageal Cancer: An International Multicenter Cohort Study

A retrospective analysis of a prospectively maintained international multicenter database comprising 2,490 patients who underwent curative-intent esophagectomy across four centers found three-field lymphadenectomy uniquely confers high recurrent laryngeal nerve palsy and chylothorax rates despite low mortality.

Si-miao Lu, Yi Zhu, Yong-Tao Han et al. · 0 citations
Open access Aug 2026

P1.072. Impact of Neoadjuvant Therapy on Survival After Esophagectomy for Squamous Cell Carcinoma: An International Multicenter Propensity Score Analysis

In this international multicenter analysis of 2,449 ESCC patients, neoadjuvant therapy was not associated with improved survival after esophagectomy and remained an independent predictor of worse OS and DFS across univariate, multivariable, PSM, and IPTW analyses.

Si-miao Lu, Yi Zhu, Qiulin Shi et al. · 0 citations
Open access Aug 2026

PD02.06. The ``Invisible Cost'' After Minimally Invasive Esophagectomy: Clinical Characteristics, Survival Impact, and Intervention Timing for Patients with Persistent Moderate-to-Severe Symptoms

Symptom persistence does not adversely affect overall survival; its association with improved DFS likely reflects the tumor-control benefit of adjuvant therapy.

Si-miao Lu, Yi Zhu, Yong-Tao Han et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.